Uncategorized

Transaction Case Studies MANA THERAPEUTICS: ROBUST DUAL-TRACK PROCESS TO A SUCCESSFUL $35M SERIES A FINANCING Situation Assessment Mana Therapeutics is […]

Transaction Case Studies SELL-SIDE ENGAGEMENT FOR GRITSTONE LEADING TO A PARTNERSHIP WITH GILEAD FOR $60M UPFRONT AND $725M IN ADDITIONAL

Transaction Case Studies M&A ADVISOR AND PIPE PLACEMENT AGENT FOR $340M ACQUISITION AND $60M PIPE Situation Assessment Locust Walk Acquisition

Transaction Case Studies RAPID FINANCING PROCESS LED TO OVERSUBSCRIBED CROSSOVER FINANCING Situation Assessment C4 Therapeutics is a private biotech with

Transaction Case Studies IPO Advisory assignment helping raise $210M in a NASDAQ IPO Situation Assessment Following the completion of a

Transaction Case Studies SUCCESSFUL CHINA SELL-SIDE LICENSING PROCESS FOR A TREATMENT FOR PEDIATRIC MYOPIA Situation Assessment Nevakar is a private

Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA

Podcast: Play in new window | Download (Duration: 35:36 — 81.5MB)

Subscribe: Apple Podcasts | Spotify | RSS

On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Kendalle Burlin O’Connell, Esq., CEO and President of MassBio, the nation’s pioneering biotechnology trade

BIO (Biotech Innovation Organization) collected a survey in January of 2020 to better understand the current demographics of biopharma companies. Responses to their questions on representation indicate that the number of women decreases at higher levels.